194 related articles for article (PubMed ID: 12958070)
21. Connective tissue growth factor induces the proliferation, migration, and tube formation of vascular endothelial cells in vitro, and angiogenesis in vivo.
Shimo T; Nakanishi T; Nishida T; Asano M; Kanyama M; Kuboki T; Tamatani T; Tezuka K; Takemura M; Matsumura T; Takigawa M
J Biochem; 1999 Jul; 126(1):137-45. PubMed ID: 10393331
[TBL] [Abstract][Full Text] [Related]
22. Structure and inhibitory effects on angiogenesis and tumor development of a new vascular endothelial growth inhibitor.
Zilberberg L; Shinkaruk S; Lequin O; Rousseau B; Hagedorn M; Costa F; Caronzolo D; Balke M; Canron X; Convert O; Laïn G; Gionnet K; Goncalvès M; Bayle M; Bello L; Chassaing G; Deleris G; Bikfalvi A
J Biol Chem; 2003 Sep; 278(37):35564-73. PubMed ID: 12837752
[TBL] [Abstract][Full Text] [Related]
23. Angiogenic effects of prostaglandin E2 are mediated by up-regulation of CXCR4 on human microvascular endothelial cells.
Salcedo R; Zhang X; Young HA; Michael N; Wasserman K; Ma WH; Martins-Green M; Murphy WJ; Oppenheim JJ
Blood; 2003 Sep; 102(6):1966-77. PubMed ID: 12791666
[TBL] [Abstract][Full Text] [Related]
24. Expression of CCR2 by endothelial cells : implications for MCP-1 mediated wound injury repair and In vivo inflammatory activation of endothelium.
Weber KS; Nelson PJ; Gröne HJ; Weber C
Arterioscler Thromb Vasc Biol; 1999 Sep; 19(9):2085-93. PubMed ID: 10479649
[TBL] [Abstract][Full Text] [Related]
25. A novel hypoxia-dependent 2-nitroimidazole KIN-841 inhibits tumour-specific angiogenesis by blocking production of angiogenic factors.
Shimamura M; Nagasawa H; Ashino H; Yamamoto Y; Hazato T; Uto Y; Hori H; Inayama S
Br J Cancer; 2003 Jan; 88(2):307-13. PubMed ID: 12610518
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of angiogenesis and angiogenesis-dependent tumor growth by the cryptic kringle fragments of human apolipoprotein(a).
Kim JS; Chang JH; Yu HK; Ahn JH; Yum JS; Lee SK; Jung KH; Park DH; Yoon Y; Byun SM; Chung SI
J Biol Chem; 2003 Aug; 278(31):29000-8. PubMed ID: 12746434
[TBL] [Abstract][Full Text] [Related]
27. CXCL1/macrophage inflammatory protein-2-induced angiogenesis in vivo is mediated by neutrophil-derived vascular endothelial growth factor-A.
Scapini P; Morini M; Tecchio C; Minghelli S; Di Carlo E; Tanghetti E; Albini A; Lowell C; Berton G; Noonan DM; Cassatella MA
J Immunol; 2004 Apr; 172(8):5034-40. PubMed ID: 15067085
[TBL] [Abstract][Full Text] [Related]
28. Hypoxia-inducible factor-1 mediates activation of cultured vascular endothelial cells by inducing multiple angiogenic factors.
Yamakawa M; Liu LX; Date T; Belanger AJ; Vincent KA; Akita GY; Kuriyama T; Cheng SH; Gregory RJ; Jiang C
Circ Res; 2003 Oct; 93(7):664-73. PubMed ID: 12958144
[TBL] [Abstract][Full Text] [Related]
29. p38 MAPK and ERK activation by 9-cis-retinoic acid induces chemokine receptors CCR1 and CCR2 expression in human monocytic THP-1 cells.
Ko J; Yun CY; Lee JS; Kim JH; Kim IS
Exp Mol Med; 2007 Apr; 39(2):129-38. PubMed ID: 17464174
[TBL] [Abstract][Full Text] [Related]
30. Hepatoma-derived growth factor is a pulmonary endothelial cell-expressed angiogenic factor.
Everett AD; Narron JV; Stoops T; Nakamura H; Tucker A
Am J Physiol Lung Cell Mol Physiol; 2004 Jun; 286(6):L1194-201. PubMed ID: 14751852
[TBL] [Abstract][Full Text] [Related]
31. Vascular smooth muscle cell growth-promoting factor/F-spondin inhibits angiogenesis via the blockade of integrin alphavbeta3 on vascular endothelial cells.
Terai Y; Abe M; Miyamoto K; Koike M; Yamasaki M; Ueda M; Ueki M; Sato Y
J Cell Physiol; 2001 Sep; 188(3):394-402. PubMed ID: 11473366
[TBL] [Abstract][Full Text] [Related]
32. Apelin is a novel angiogenic factor in retinal endothelial cells.
Kasai A; Shintani N; Oda M; Kakuda M; Hashimoto H; Matsuda T; Hinuma S; Baba A
Biochem Biophys Res Commun; 2004 Dec; 325(2):395-400. PubMed ID: 15530405
[TBL] [Abstract][Full Text] [Related]
33. Possible angiogenic roles of insulin-like growth factor II and its receptors in uterine vascular adaptation to pregnancy.
Herr F; Liang OD; Herrero J; Lang U; Preissner KT; Han VK; Zygmunt M
J Clin Endocrinol Metab; 2003 Oct; 88(10):4811-7. PubMed ID: 14557459
[TBL] [Abstract][Full Text] [Related]
34. Eotaxin/CCL11 suppresses IL-8/CXCL8 secretion from human dermal microvascular endothelial cells.
Cheng SS; Lukacs NW; Kunkel SL
J Immunol; 2002 Mar; 168(6):2887-94. PubMed ID: 11884459
[TBL] [Abstract][Full Text] [Related]
35. CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts.
Yu X; Huang Y; Collin-Osdoby P; Osdoby P
J Bone Miner Res; 2004 Dec; 19(12):2065-77. PubMed ID: 15537451
[TBL] [Abstract][Full Text] [Related]
36. SDF-1 activity on microvascular endothelial cells: consequences on angiogenesis in in vitro and in vivo models.
Mirshahi F; Pourtau J; Li H; Muraine M; Trochon V; Legrand E; Vannier J; Soria J; Vasse M; Soria C
Thromb Res; 2000 Sep; 99(6):587-94. PubMed ID: 10974345
[TBL] [Abstract][Full Text] [Related]
37. Cell cycle-dependent expression of CXC chemokine receptor 3 by endothelial cells mediates angiostatic activity.
Romagnani P; Annunziato F; Lasagni L; Lazzeri E; Beltrame C; Francalanci M; Uguccioni M; Galli G; Cosmi L; Maurenzig L; Baggiolini M; Maggi E; Romagnani S; Serio M
J Clin Invest; 2001 Jan; 107(1):53-63. PubMed ID: 11134180
[TBL] [Abstract][Full Text] [Related]
38. The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR+ CXC chemokine-induced angiogenic activity.
Addison CL; Daniel TO; Burdick MD; Liu H; Ehlert JE; Xue YY; Buechi L; Walz A; Richmond A; Strieter RM
J Immunol; 2000 Nov; 165(9):5269-77. PubMed ID: 11046061
[TBL] [Abstract][Full Text] [Related]
39. Domain swapping in a COOH-terminal fragment of platelet factor 4 generates potent angiogenesis inhibitors.
Hagedorn M; Zilberberg L; Wilting J; Canron X; Carrabba G; Giussani C; Pluderi M; Bello L; Bikfalvi A
Cancer Res; 2002 Dec; 62(23):6884-90. PubMed ID: 12460903
[TBL] [Abstract][Full Text] [Related]
40. Down-modulation of monocyte transendothelial migration and endothelial adhesion molecule expression by fibroblast growth factor: reversal by the anti-angiogenic agent SU6668.
Zhang H; Issekutz AC
Am J Pathol; 2002 Jun; 160(6):2219-30. PubMed ID: 12057924
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
